CDC’s Director Inquired into Deceased 13-Year-Old Boy Just Two Days After Vaccination

A conservative watchdog group accessed 314 pages of Centers for Disease Control and Prevention (CDC) records, indicating the federal public health agency’s director was concerned about a possible COVID-19 vaccine-related death. The Judicial Watch secured a trove of documents via a Freedom of Information Act (FOIA) request that reveals  Rochelle Walensky issued a request to uncover more details about a teenager who died after receiving the COVID-19 vaccine.

An article titled, “CDC reportedly probing Michigan teen’s death after COVID-19 vaccination” on June 28 apparently got the attention of the top federal bureaucrat, as she sent a communication to Dr. Henry Walke, director of CDC’s Division of Preparedness and Emerging Infections, who received the request from the director declaring “Any details on this?” The email found its way to another CDC executive, David Fitter who answered, “The case had been reported to VAERS [CDC’s Vaccine Adverse Event Reporting System]. CDC has spoken with ME [Medical Examiner], but we are following protocol for f/u [follow-up] re the case. Additionally, CDC remains in contact with MI to assist in the investigation,” as reported by Judicial Watch.

Investigation

The FOIA documentation reveals that another CDC official named Jennifer Layden followed up on this communication thread, noting the case was working its way through VAERS and their internal review process.

What happened to the deceased?

The deceased is a 13-year-old healthy boy with no apparent medical history. Two days after he was vaccinated, the boy was found “unresponsive.” The only sign of any health trouble had been a fever, but nothing else was noticeably wrong. 

The initial pathologist report points to “bilateral ventricular enlargement and histology consistent with myocarditis,” but these are preliminary findings.

CDC Safety Team Status—Nothing Urgent?

In response, a CDC safety team email revealed that “CDC is not actively involved in this investigation (i.e., IDPB examining specimens). The representative from the safety team communicated that the matter was underway with a state health department and pathologist who performed an autopsy and they “are in touch to maintain situational awareness.”  

The CDC appears to be communicating that the whole investigation is in limbo, declaring, “The autopsy was completed when we contacted the state health department and no request for CDC assistance has been made.”

So now that an autopsy report is pending finality, the CDC and the state health department communicate about the case while its remains under investigation.

Clinical Trial Discussions: ADE

The Judicial Watch cache also highlights an email between Christie Blomquist, AstraZeneca’s vice president for corporate affairs, North America and Walensky. The former sent the latter a press release stating that “The reduced Fc receptor binding aims to minimize the risk of antibody-dependent enhancement of disease – a phenomenon in which virus-specific antibodies promote, rather than inhibit, infection and/or disease.”

By July 26, 2021, Judicial Watch shared also that Walensky received study information via email from a redacted person titled “Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine.” This study included 44,165 randomized participants. The unknown email sender declared “Of these participants, 44,060 were vaccinated with 2:1 dose (BNT162b2, n=22,030; placebo, n=22,030), and 98% received dose 2 (Fig.l). During the blinded period, 51% of participants in each group had 4 to <6 months of follow-up post-dose 2; 8% of BNT162b2 recipients and 6% of placebo recipients had 2:6 months follow-up post-dose 2.”

What about AEs?

The email communication concerning the Pfizer mRNA study revealed, “Adverse event analyses during the blinded period are provided for 43,847 2:16-year-olds (Table S3). Reactogenicity events among participants not in the reactogenicity subset are reported as adverse events, resulting in imbalances in adverse events (30% vs 14%), related adverse events (24% vs 6%), and severe adverse events (1.2% vs 0.7%) between BNT162b2 and placebo groups.”

Moreover, the Judicial Watch press release reveals the CDC discussed new adverse events such as “Decreased appetite, lethargy, asthenia, malaise, night sweats, and hyperhidrosis.”

TrialSite’s Sonia Elijah recently reported on some concerning safety information associated with the Pfizer vaccine and another cache of documents via FOIAThe BMJ reported that a whistleblower alleged that a contract research organization involved with the BNT162b2 clinical trial was involved with quality control problems and possibly data manipulation issues. Senior editors from The BMJ had to write a complaint to Mark Zuckerberg after Facebook fact-checkers made that story disappear.

What is Judicial Watch?

A conservative activist group, Judicial Watch was originally organized to go after corruption and waste at the federal level of government. It was initially targeted to go after Democrats in 1994, with a particular focus on then-President Bill Clinton.

The organization is known to be heavily biased against Democratic operatives versus corrupt Republicans which they seem to not investigate much. The group is known for FOIA efforts combined with lawsuits. They deny global warming and align with several other controversial positions. Regardless, activist groups demanding more federal transparency, considering the pandemic, federal mandates, safety concerns, and the like are important regardless of political ideology at this stage.